News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

LifeSci Advisors, LLC (LSA) Announces Investment Opinion on Neoprobe Corporation (NEOP)


3/9/2011 10:54:50 AM

NEW YORK--(BUSINESS WIRE)--LifeSci Advisors, LLC, a leading provider of investment research and investor relations services in the life sciences sector, today announced that it has initiated coverage of Neoprobe Corporation (NYSE Amex: NEOP), a diversified developer of innovative oncology surgical and diagnostic products. Neoprobe is a world leader in gamma detection technology and is the only company marketing gamma detection devices working to optimize both radiotracers and gamma detection hardware.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES